Q2 2021 Results - Reimagining Medicine slide image

Q2 2021 Results - Reimagining Medicine

Participants Company overview Pharmaceuticals Oncology Financial performance CRM IHD Neuroscience Oncology Ophthalmology Financial review Conclusion Appendix Innovation: Pipeline overview Immunology, Hepatology & Dermatology 70 Investor Relations | Q2 2021 Results Respiratory References Innovation: Clinical trials Sandoz Biopharmaceuticals Global Health Abbreviations NOVARTIS | Reimagining Medicine
View entire presentation